XML 23 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Paid in Capital
Statutory Reserves
Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 2,033 $ 116,682,374 $ 14,525,712 $ (6,132,614) $ (46,447,959) $ 78,629,546
Balance (in Shares) at Dec. 31, 2019 2,032,721          
Net income (loss)   (598,551) (598,551)
Issuance of common stock for stock compensation $ 3 10,996   10,999
Issuance of common stock for stock compensation (in Shares) 3,333          
Conversion of long-term notes into common shares $ 143 533,024   533,167
Conversion of long-term notes into common shares (in Shares) 143,333          
Foreign currency translation gain (loss)   (1,341,276)   (1,341,276)
Balance at Mar. 31, 2020 $ 2,179 117,226,394 14,525,712 (7,473,890) (47,046,510) 77,233,885
Balance (in Shares) at Mar. 31, 2020 2,179,387          
Net income (loss)   993,940 993,940
Conversion of long-term notes into common shares $ 305 769,444   769,749
Conversion of long-term notes into common shares (in Shares) 304,710          
Round-up of fractional shares due to reverse split $ 9 (9)  
Round-up of fractional shares due to reverse split (in Shares) 9,100          
Transfer to Statutory Reserves   140,494   (140,494)  
Foreign currency translation gain (loss)   58,688   58,688
Balance at Jun. 30, 2020 $ 2,493 117,995,829 14,666,206 (7,415,202) (46,193,064) 79,056,262
Balance (in Shares) at Jun. 30, 2020 2,493,197          
Net income (loss)         (671,280) (671,280)
Conversion of long-term notes into common shares $ 243 635,779       636,022
Conversion of long-term notes into common shares (in Shares) 242,699          
Shares issued for equity financing $ 265 496,922       497,187
Shares issued for equity financing (in Shares) 265,250          
Transfer to Statutory Reserves     1,198   (1,198)  
Foreign currency translation gain (loss)       3,456,157   3,456,157
Balance at Sep. 30, 2020 $ 3,001 119,128,530 14,667,404 (3,959,045) (46,865,542) 82,974,348
Balance (in Shares) at Sep. 30, 2020 3,001,146          
Balance at Dec. 31, 2020 $ 3,177 119,748,999 15,155,042 273,440 (43,026,465) 92,154,193
Balance (in Shares) at Dec. 31, 2020 3,177,050          
Net income (loss) (277,224) (277,224)
Shares to be issued 38,253,041 38,253,041
Transfer to Statutory Reserves 1,538   (1,538)  
Foreign currency translation gain (loss) (1,140,163)   (1,140,163)
Balance at Mar. 31, 2021 $ 3,177 158,002,040 15,156,580 (866,723) (43,305,227) 128,989,847
Balance (in Shares) at Mar. 31, 2021 3,177,050          
Net income (loss)   2,220,571 2,220,571
Conversion of long-term notes into common shares $ 54 502,665   502,719
Conversion of long-term notes into common shares (in Shares) 54,348          
Issuance of common stock for equity financing $ 3,320 (3,320)    
Issuance of common stock for equity financing (in Shares) 3,320,000          
Return of shares issued to CEO for equity financing $ (60) (691,260)   (691,320)
Return of shares issued to CEO for equity financing (in Shares) (60,000)          
Transfer to Statutory Reserves 14,774   (14,774)  
Foreign currency translation gain (loss) 2,407,848   2,407,848
Balance at Jun. 30, 2021 $ 6,491 157,810,125 15,171,354 1,541,125 (41,099,430) 133,429,665
Balance (in Shares) at Jun. 30, 2021 6,491,398          
Net income (loss)         (556,574) (556,574)
Conversion of long-term notes into common shares $ 207 1,558,228       1,558,435
Conversion of long-term notes into common shares (in Shares) 206,382          
Stock compensation expense $ 31 223,407       $ 223,438
Stock compensation expense (in Shares) 31,250          
Return of shares issued to CEO for equity financing (in Shares)           31,250
Transfer to Statutory Reserves     3,273   (3,273)  
Foreign currency translation gain (loss)       (565,170)   $ (565,170)
Balance at Sep. 30, 2021 $ 6,729 $ 159,591,760 $ 15,174,627 $ 975,955 $ (41,659,277) $ 134,089,794
Balance (in Shares) at Sep. 30, 2021 6,729,030